Susquehanna International Group
ENSC icon

Susquehanna International Group’s Ensysce Biosciences ENSC Stock Holding History

Susquehanna International Group’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19
Closed -$60K – 13399
2022
Q2 		$60K Sell
19
-6
-24% -$16.8K ﹤0.01% 11868
2022
Q1 		$102K Buy
+25
New +$165K ﹤0.01% 11895

Other funds holding ENSC

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
PIA
Powell Investment Advisors Miami, Florida $317M AUM 26.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $1.55B AUM 17.93% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's ENSC Position: Q1 2023 in Review

Susquehanna International Group sold out of Ensysce Biosciences (ENSC) in Q1 2023, closing a stake of 98 shares — an estimated $13.2K sold.

Susquehanna International Group first reported a position in ENSC in Q2 2022 and held it in 2 quarters. The position peaked at $13.2K in Q4 2022. 8 funds tracked by Wall St. Rank hold ENSC as of Q1 2023.

  • Susquehanna International Group reported no remaining Ensysce Biosciences position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 98 Ensysce Biosciences shares in Q1 2023, an estimated $13.2K.
  • Susquehanna International Group first reported a position in Ensysce Biosciences in Q2 2022 and held it in 2 quarters.
  • Susquehanna International Group's Ensysce Biosciences position peaked at $13.2K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.